Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...

Beyond Dryness: Why Sjögren’s Syndrome Requires Multiple Treatment Paths

Effective Sjögren’s management demands a strict separation between symptomatic relief for sicca and immunosuppression for ...

AstraZeneca: Oncology Dominance Justifies New All-Time Highs

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

AstraZeneca’s DAHLIA Lupus Study: Real‑World Data Could Strengthen Anifrolumab’s Long‑Term Investment Case

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Alumis Inc.: Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated ...